Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Dec;42(12):5846-8.
doi: 10.1128/JCM.42.12.5846-5848.2004.

Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients

A K Burn  1 , A W Fothergill, W R Kirkpatrick, B J Coco, T F Patterson, D I McCarthy, M G Rinaldi, S W Redding
Affiliations
Comparative Study

Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients

A K Burn et al. J Clin Microbiol. 2004 Dec.

Abstract

The antifungal susceptibilities of 79 oral Candida glabrata isolates to fluconazole and voriconazole were compared. The MICs at which 90% of the isolates tested were inhibited were 1 microg of voriconazole/ml and 32 microg of fluconazole/ml. Oral C. glabrata isolates for which the fluconazole MICs are elevated are commonly those for which the voriconazole MICs are elevated, but these increases may be transient for voriconazole, as they are for fluconazole.

PubMed Disclaimer

References

    1. Di Francesco, L., F. Barchiesi, F. Caselli, O. Cirioni, and F. Scalise. 1999. Comparison of four methods for DNA typing of clinical isolates of Candida glabrata. J. Med. Microbiol. 48:955-963. - PubMed
    1. Espinel-Ingroff, A. 1998. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J. Clin. Microbiol. 36:198-202. - PMC - PubMed
    1. Marr, K. A., C. N. Lyons, T. Rustad, R. A. Bowden, and T. C. White. 1998. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR. Antimicrob. Agents Chemother. 42:2584-2589. - PMC - PubMed
    1. Muijsers, R. B. R., K. L. Goa, and L. J. Scott. 2002. Voriconazole: in the treatment of invasive aspergillosis. Drugs 62:2655-2664. - PubMed
    1. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.

Publication types

MeSH terms